Main sector:
Biotechnology - Therapeutics and Diagnostics
Subsectors:
Anti-infectives
Nucleic acid drugs
Small molecules
Indications:
Infectious and parasitic diseases / infectiology / parasitology
Neoplasms / cancer / oncology
Mental and behavioural disorders / psychiatry /psychology
Diseases of the nervous system / neurology
Diseases of the eye / ophthalmology
Digestive system / gastroenterology
Skin and subcutaneous tissue / dermatology
Genitourinary system / Urology
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Social circumstances / substance related disorders / addiction
Products
In development: 24
On the market: 4
Description:
Vanda Pharmaceuticals Inc. is a global biopharmaceutical company focused on the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. The company's products include HETLIOZ® (tasimelteon) for Non-24 and nighttime sleep disturbances in SMS, Fanapt® (iloperidone) for schizophrenia and the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults, PONVORY® (ponesimod) for relapsing forms of multiple...
